News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytoDyn Presenting Update on its Therapeutic Antibody Programs at the Therapeutic Potential of Antibodies for HIV Meeting in Boston, MA


1/17/2012 5:54:29 AM

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn Inc. (the "Company")(OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency virus and other antibody applications, announced today that it is presenting an update on its Human Immunodeficiency Virus ("HIV") and Feline Immunodeficiency Virus ("FIV") therapeutic antibody programs, including new preclinical findings, at the Therapeutic Potential of Antibodies for HIV meeting sponsored by Search For A Cure, Inc. in Boston, Massachusetts.

Read at BioSpace.com


comments powered by Disqus
CytoDyn
 
 
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES